 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
RXi Gets Spun Out of Galena, Names New CEO as it Loses Its CSO
May 10, 2012
RXi Gets Spun Out of Galena, Names New CEO as it Loses Its CSO
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Galena Settles Investor Lawsuits Following Successful RXi Spinout
June 14, 2012 / Gene Silencing News - Galena Makes Payment to Investors to Settle Securities Litigation
March 29, 2012 / Gene Silencing News - Galena Hit with Fourth Investor Lawsuit Related to Planned RXi Spinout
February 9, 2012 / Gene Silencing News - Galena Slapped with Third Investor Lawsuit Related to Planned RXi Spin Out
January 26, 2012 / Gene Silencing News - RXi Q1 Loss Rises on Opko Deal Charge
May 16, 2013 / Gene Silencing News